Abstract
Uroguanylin (gene name: guanylate cyclase activator 2B, GUCA2B) is a peptide regulator of intestinal salt and water transport. It has been reported that the uroguanylin knockout mouse exhibits elevated blood pressure. Therefore, the GUCA2B gene is thought to be a susceptibility gene for essential hypertension (EH). Despite extensive studies, however, the relationship between the GUCA2B gene and EH has not yet been defined. The aim of this study was to assess the association between the human GUCA2B gene and EH. Using four single nucleotide polymorphisms (SNPs), we conducted a genetic association study in 281 EH patients and 279 age-matched normotensive (NT1) individuals. To derive more reliable data, we performed a duplicate case-control study in which we recruited another normotensive group (NT2). There was no significant difference in the overall distribution of alleles for any of the SNPs between the EH and NT1 groups, or between the EH and NT2 groups. Therefore, these four SNPs cannot be the genetic markers for EH. The occurrences of the C-A haplotype (rs883062-rs1047047) and the C-A-G haplotype (rs883062-rs1047047-rs2297566) were significantly higher in the EH group than in the NT1 group (p<0.0001) or the NT2 group (p<0.0001). These results suggest that the C-A haplotype and the C-A-G haplotype of the GUCA2B gene are the genetic markers for EH, and that GUCA2B or a neighboring gene might be a susceptibility gene for EH.
Similar content being viewed by others
Article PDF
References
Lorenz JN, Nieman M, Sabo J, et al: Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response toenteral NaCl load. J Clin Invest 2003; 112: 1244–1254.
Hamra FK, Forte LR, Eber SL, et al: Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci U S A 1993; 90: 10464–10468.
Schulz S, Green CK, Yuen PS, et al: Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell 1990; 63: 941–948.
Forte LR, Fan X, Hamra FK : Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity. Am J Kidney Dis 1996; 28: 296–304.
Forte LR, London RM, Freeman RH, et al: Guanylin peptide: renal actions mediated mediated by cyclic GMP. Am J Physiol Renal Physiol 2000; 278: F180–F191.
Forte LA, London RM, Krause WJ, et al: Mechanisms of guanylin action via cyclic GMP in the kidney. Annu Rev Physiol 2000; 62: 673–695.
Hess R, Kuhu M, Schulz-Knappe P, et al: GCAP-II: isolation and characterization of the circulating form of human uroguanylin. FEBS Lett 1995; 374: 34–38.
Martin S, Adermann K, Forssmann WG, et al: Regulated, side-directed secretion of proguanylin from isolated rat colonic mucosa. Endocrinology 1999; 140: 5022–5029.
Carrithers SL, Jackson BA, Cai WY, et al: Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine. Regul Pept 2002; 107: 87–95.
Potthast R, Ehler E, Scheving LA, et al: High salt intake increases uroguanylin expression in mouse kidney. Endocrinology 2001; 142: 3087–3097.
Kinoshita H, Fujimoto S, Nakazato M, et al: Urine and plasma levels of uroguanylin and its molecular forms in renal diseases. Kidney Int 1997; 52: 1028–1034.
Kinoshita H, Fujimoto S, Fukae H, et al: Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron 1999; 81: 160–164.
Carrithers SL, Eber SL, Forte LR, et al: Increased urinary excretion of uroguanylin in patients with congestive heart failure. Am J Physiol Heart Circ Physiol 2000; 278: H538–H547.
Miyazato M, Nakazato M, Matsukura S, et al: Genomic structure and chromosomal localization of human uroguanylin. Genomics 1997; 43: 359–365.
Miyazato M, Nakazato M, Yamaguchi H, et al: Cloning and characterization of a cDNA encoding a precursor for human uroguanylin. Biochem Biophys Res Commun 1996; 219: 644–648.
Nakazato M, Yamaguchi H, Date Y, et al: Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin. Endocrinology 1998; 139: 5247–5254.
Dominiczak AF, Negrin DC, Clark JS, et al: Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35: 164–172.
Morita A, Nakayama T, Doba N, Hinohara S, Soma M : Polymorphism of the C reactive protein gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29: 323–331.
Nakayama T, Soma M, Mizutani Y, et al: A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. Hypertens Res 2002; 25: 395–401.
Hasimu B, Nakayama T, Mizutani Y, et al: A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension. Hypertens Res 2003; 26: 473–477.
Aoi N, Soma M, Nakayama T, et al: Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004; 27: 711–716.
Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M : Haplotype-based case-control study of adrenomedullin genes on proteinuria in the subjects with essential hypertension. Hypertens Res 2005; 28: 229–236.
Dempster AP, Laird NM, Rubin DB : Maximum likelihood from in complete data via the EM algorithm. J R Stat Soc 1977; 39: 1–22.
Nakayama T, Soma M, Takahashi Y, et al: Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet 1997; 51: 26–30.
Excoffier L, Slatkin M : Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921–927.
Kaneko Y, Nakayama T, Saito K, et al: Relationship between the thromboxane A2 receptor gene and susceptibility to cerebral infarction. Hypertens Res 2006; 29: 665–671.
Sindic A, Velic A, Basoglu C, et al: Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C. Kidney Int 2005; 68: 1008–1017.
Ozaki K, Ohnishi Y, Iida A, et al: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650–654.
Zhang K, Calabrese P, Nordborg M, Sun F : Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 2002; 71: 1386–1394.
Morris RW, Kaplan NL : On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221–233.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoshikawa, Y., Nakayama, T., Saito, K. et al. Haplotype-Based Case-Control Study of the Association between the Guanylate Cyclase Activator 2B (GUCA2B, Uroguanylin) Gene and Essential Hypertension. Hypertens Res 30, 789–796 (2007). https://doi.org/10.1291/hypres.30.789
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.789